Akèy › Rabdomiyosakòm › Alabama › Birmingham
Etid klinik pou Rabdomiyosakòm nan Birmingham, AL
3 etid pou Rabdomiyosakòm ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Ap rekriteFaz 1/2
- University of Alabama/Children's of Alabama, Birmingham
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Ap rekriteFaz 3
- Children's Hospital of Alabama, Birmingham
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Ap rekriteFaz 2
- Children's Hospital of Alabama/UAB, Birmingham
Etid Rabdomiyosakòm nan lòt vil
- Houston, TX6 etid
- Memphis, TN6 etid
- Washington, DC5 etid
- Salt Lake City, UT4 etid
- Boston, MA4 etid
- Philadelphia, PA4 etid
- Seattle, WA3 etid
- Aurora, CO3 etid
- Dallas, TX3 etid
- The Bronx, NY3 etid
- Baltimore, MD3 etid
Lòt etid nan Birmingham
- Kansè (tout kalite)30 etid
- Kansè nan tete24 etid
- Obèsite23 etid
- Kansè ovè23 etid
- Kansè Poumon ki pa ti selil22 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip18 etid
- BPCO17 etid
- Maladi kadyovaskilè17 etid
- Sipwa16 etid
- Kansè Endomèt16 etid
- Dyabèt Tip 216 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.